Progression-free survival (PFS) and toxicity with nivolumab-AVD compared to brentuximab vedotin-AVD in pediatric advanced stage (AS) classic Hodgkin lymphoma (cHL), results of SWOG S1826 Meeting Abstract
| Authors: | Castellino, S. M.; Li, H.; Herrera, A. F.; Punnett, A.; Leblanc, M.; Parsons, S. K.; Hodgson, D.; Keller, F.; Drachtman, R. A.; Lamble, A.; Forlenza, C. J.; Doan, A.; Rutherford, S. C.; Evens, A. M.; Little, R. F.; Smith, M. A.; Song, J. Y.; Smith, S. M.; Friedberg, J. W.; Kelly, K. M. |
| Abstract Title: | Progression-free survival (PFS) and toxicity with nivolumab-AVD compared to brentuximab vedotin-AVD in pediatric advanced stage (AS) classic Hodgkin lymphoma (cHL), results of SWOG S1826 |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 610 |
| Language: | English |
| ACCESSION: | WOS:001159306702123 |
| DOI: | 10.1182/blood-2023-180107 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
